Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130071) titled 'Channelling Algorithm Proficiency To Understand, Recognise and Elucidate Disease' on Aug. 12.
Study Type: Observational
Primary Sponsor: Research in Real-Life Ltd
Condition:
Rare Disorders
Recruitment Status: Not recruiting
Date of First Enrollment: October 2025
Target Sample Size: 500
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130071
Published by HT Digital Content Services with permission from Health Daily Digest....